Skip to main content
. Author manuscript; available in PMC: 2024 Jan 1.
Published in final edited form as: J Addict Med. 2022 Dec 13;17(3):e192–e198. doi: 10.1097/ADM.0000000000001123

Table 2:

Perinatal outcomes in cannabis use disorder vs no cannabis use in California

Total Cannabis use disorders No Cannabis Use P*
N=2,380,446 N=9,144 N=2,371,302
Birthing patient outcomes
Gestational hypertension 62,601 (2.6%) 350 (3.8%) 62,251 (2.6%) <0.001
Preterm delivery (<37 weeks) 159,229 (6.7%) 1,299 (14.2%) 157,930 (6.7%) <0.001
Pre-eclampsia 90,487 (3.8%) 474 (5.2%) 90,013 (3.8%) <0.001
Severe maternal morbidity 21,798 (0.9%) 158 (1.7%) 21,640 (0.9%) <0.001
Neonatal outcomes
Intrauterine fetal death 9,187 (0.4%) 91 (1.0%) 9,096 (0.4%) <0.001
Infant death 4,426 (0.2%) 86 (0.9%) 4,340 (0.2%) <0.001
NICU admission 205,757 (9.0%) 1,631 (18.2%) 204,126 (8.9%) <0.001
Small for gestational age 202,611 (8.5%) 1,459 (16.0%) 201,152 (8.5%) <0.001
Respiratory distress syndrome 130,659 (5.5%) 906 (9.9%) 129,753 (5.5%) <0.001
Hypoglycemia 19,022 (0.8%) 126 (1.4%) 18,896 (0.8%) <0.001
*

Chi-square test